Write your message
Volume 1, Issue 2 (9-2016)                   J Obstet Gynecol Cancer Res 2016, 1(2): 0-0 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hasanzadeh M, Ahmadi S. New Topics on HPV in EUROGIN 2016. J Obstet Gynecol Cancer Res. 2016; 1 (2)
URL: http://jogcr.com/article-1-113-en.html
1- Fellowship of Gynecology Oncology, Mashhad University of Medical Sciences, Mashhad, IR Iran , hasanzademofradm@mums.ac.ir
2- Gynecologist, Iran University of Medical Sciences, Tehran, IR Iran
Abstract:   (1545 Views)

Background: Human papillomavirus (HPV) is thought to be the most common sexually transmitted viral disease. This infection continues to be an important topic. One of the most important conferences on human papillomavirus infection and related cancers is EUROGIN. The program also includes state of the art science on anogenital and head and neck cancer, inspiration, cooperation, and forums to share expertise and learn from leading experts in the field.
Methods: We reported an abstract of important articles and researches presented in this congress.
Results: HPV had rolled in oropharyngeal cancer. KI67/P16 is important for deciding on treatment of patients with HPV high-risk positive. Methylation can be used in the management of HPV high-risk patients. 9-valent HPV vaccination can prevent different anogenital cancers.
Conclusions: HPV has important role in different cancers. HPV vaccination can prevent a variety of anogenital cancers related to HPV.

Full-Text [PDF 66 kb]   (628 Downloads)    
Systematic Review: Original Research | Subject: Obstetrics and Gynecology
Received: 2018/05/4 | Accepted: 2018/12/29 | Published: 2018/12/29

References
1. Clifford G, Franceschi S, Plummer M, De Martel C. The burden of HPV associated cancers in men and women. ; 2016.
2. De Sanjose S. The state of the art of HPV epidemiology, cervical vs oral. EUROGIN; 2016.
3. Joura E, Garland S, Giuliano A, Bautista O. Efficacy for vulvovaginal disease of the 9-valent hpv vaccine in 16-26 year old women. Luxembourg: EUROGIN; 2016.
4. Wentzensen N. P16 for triage of HPV-positive women. Eurogin; 2016.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.